An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target

Mahil, SK, Catapano, M, Di Meglio, P et al. (10 more authors) (2017) An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Science Translational Medicine, 9 (411). eaan2514. ISSN 1946-6234

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2017, The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an author produced version of a paper published in Science Translational Medicine. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 11 October 2017
  • Accepted: 21 August 2017
  • Published (online): 11 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds) > Genetics (LIBACS) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Jul 2018 14:11
Last Modified: 23 Jul 2018 14:12
Status: Published
Publisher: American Association for the Advancement of Science
Identification Number: https://doi.org/10.1126/scitranslmed.aan2514
Related URLs:

Share / Export

Statistics